Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex
oleh: Renan Le Cras, Roseline Mazet, Fanny Dubois-Teklali, Cécile Sabourdy, Sébastien Chanoine, Audrey Lehmann, Agathe Morin, Julien Leenhardt, Marjorie Durand, Marie-Dominique Desruet, Pierrick Bedouch
| Format: | Article |
|---|---|
| Diterbitkan: | Taylor & Francis Group 2023-12-01 |
Deskripsi
ABSTRACTSubacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon-α2b (INF-α2b) injections and oral inosiplex and how we continued the treatment when inosiplex was commercially stopped worldwide.